Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort

Phase 3

Active, not recruiting

Conditions: In-Stent Restenosis

Interventions: Device: AGENT DCB 40 mm

First Posted Date: 2024-07-09

Last Posted Date: 2025-06-24

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 20

Registration Number: NCT06492174

Locations: 🇺🇸
Carondelet Medical Group St. Mary's Hospital, Tucson, Arizona, United States
🇺🇸
Cedars Sinai Medical Center, Los Angeles, California, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

and more 8 locations

SpaceIT Hydrogel System for Perirectal Spacing

Not Applicable

Recruiting

Conditions: Prostate Cancer

Interventions: Device: SpaceIT Hydrogel System
Device: Commercially available Boston Scientific Spacer

First Posted Date: 2024-06-11

Last Posted Date: 2025-06-15

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 230

Registration Number: NCT06451614

Locations: 🇺🇸
Ronald Reagan UCLA Medical Center, Los Angeles, California, United States
🇺🇸
Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States
🇺🇸
Midtown Urology Associates, Austin, Texas, United States

and more 13 locations

ADVENT Post Approval Study

Recruiting

Conditions: Paroxysmal Atrial Fibrillation

First Posted Date: 2024-05-29

Last Posted Date: 2025-06-27

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 220

Registration Number: NCT06431815

Locations: 🇺🇸
Mobile Infirmary Medical Center, Mobile, Alabama, United States
🇺🇸
Scottsdale Healthcare - Shea, Scottsdale, Arizona, United States
🇺🇸
Alta Bates Summit Medical Center, Oakland, California, United States

and more 31 locations

Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device

Not Applicable

Recruiting

Conditions: Cancer
Prostate

Interventions: Device: TheraSphere PCa

First Posted Date: 2024-01-05

Last Posted Date: 2025-06-29

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 36

Registration Number: NCT06192758

Locations: 🇺🇸
Ronald Reagan UCLA Medical Center (UCLA Health, Los Angeles), Los Angeles, California, United States
🇺🇸
University of Miami (Sylvester Comprehensive Cancer Center), Miami, Florida, United States
🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States

and more 2 locations

Feasibility Study on the FARAVIEW Technology

Not Applicable

Completed

Conditions: Paroxysmal Atrial Fibrillation
Persistent Atrial Fibrillation
Atrial Fibrillation

Interventions: Device: Ablation Treatment

First Posted Date: 2023-12-18

Last Posted Date: 2025-06-27

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 50

Registration Number: NCT06175234

Locations: 🇨🇿
Na Homolce Hospital, Prague, Czechia
🇮🇪
Mater Private Hospital, Dublin, Ireland
🇪🇸
Clínica Universidad de Navarra, Pamplona, Navarra, Spain

AXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE

Not Applicable

Recruiting

Conditions: Gastric Outlet Obstruction

Interventions: Device: AXIOS(TM) Stent and Electrocautery Enhanced Delivery System

First Posted Date: 2023-12-18

Last Posted Date: 2025-06-18

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 67

Registration Number: NCT06174805

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
New York Presbyterian/ Weill Cornell Medical Center, New York, New York, United States

and more 7 locations

Obsidio™ Conformable Embolic Registry

Recruiting

Conditions: Hypervascular Tumors
Hemorrhage
Bleeding

Interventions: Device: Obsidio™ Conformable Embolic

First Posted Date: 2023-12-14

Last Posted Date: 2025-06-27

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 125

Registration Number: NCT06170619

Locations: 🇺🇸
Mayo Clinic Hospital, Phoenix, Arizona, United States
🇺🇸
Ronald Reagan UCLA Medical Center, Los Angeles, California, United States
🇺🇸
St. Joseph's Medical Center, Stockton, California, United States

and more 17 locations

POLARx Post Approval Study (POLARx PAS)

Not Applicable

Recruiting

Conditions: Paroxysmal Atrial Fibrillation

Interventions: Device: Boston Scientific Cardiac Cryoablation System

First Posted Date: 2023-12-14

Last Posted Date: 2025-06-27

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 200

Registration Number: NCT06170606

Locations: 🇺🇸
Mercy Gilbert Medical Center, Gilbert, Arizona, United States
🇺🇸
Banner University Medical Center Phoenix, Phoenix, Arizona, United States
🇺🇸
Pima Heart & Vascular Clinical Research, Tucson, Arizona, United States

and more 18 locations

VITALYST Early Feasibility Study in High-Risk PCI Patients (VITALYST EFS)

Not Applicable

Completed

Conditions: High-risk Percutaneous Coronary Intervention
Heart Disease, Coronary

Interventions: Device: VITALYST System

First Posted Date: 2023-11-15

Last Posted Date: 2025-06-22

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 15

Registration Number: NCT06132568

Locations: 🇺🇸
Piedmont Heart Institute, Atlanta, Georgia, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

and more 2 locations

Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation

Not Applicable

Active, not recruiting

Conditions: Persistent Atrial Fibrillation

Interventions: Device: FARAPULSE™ Pulsed Field Ablation (PFA) System

First Posted Date: 2023-10-23

Last Posted Date: 2025-06-25

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 484

Registration Number: NCT06096337

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Banner University Medical Center Phoenix, Phoenix, Arizona, United States
🇺🇸
Phoenix Cardiovascular Research Group, Phoenix, Arizona, United States

and more 63 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy